IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지

Ulcerative Colitis is Associated with Novel Polymorphisms in the Promoter Region of MIP-3${\alpha}$/CCL20 Gene

  • Choi, Suck-Chei (Digestive Disease Research Institute) ;
  • Lee, Eun-Kyung (Department of Physiology, Kyungpook National University School of Medicine) ;
  • Lee, Sung-Ga (Department of Physiology, Kyungpook National University School of Medicine) ;
  • Chae, Soo-Cheon (Genome Research Center for Immune Disorders, Wonkwang University School of Medicine) ;
  • Lee, Myeung-Su (Digestive Disease Research Institute) ;
  • Seo, Geom-Seog (Digestive Disease Research Institute) ;
  • Kim, Sang-Wook (Department of Internal Medicine, Chonbuk National University College of Medicine) ;
  • Yeom, Joo-Jin (Department of Internal Medicine, Chonbuk National University College of Medicine) ;
  • Jun, Chang-Duk (Department of Physiology, Kyungpook National University School of Medicine)
  • Published : 2005.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: We examined global gene expression profiles of peripheral blood mononuclear cells (PBMCs) in patients with ulcerative colitis (DC), and tested whether the identified genes with the altered expression might be associated with susceptibility to UC. Methods: PBMCs from 8 UC and 8 normal healthy (NH) volunteers were collected, and total RNAs were subjected to the human 8.0K cDNA chip for the micro array analysis. Real time-PCR (RT-PCR) was performed to verify the results of micro array. One hundred forty UC patients and 300 NH controls were recruited for single nucleotide polymorphism (SNP) analysis. Results: Twenty-five immune function-related genes with over 2-fold expression were identified. Of these genes, two chemokines, namely, CXCL1 and CCL20, were selected because of their potential importance in the evocation of host innate and adaptive immunity. Four SNPs were identified in the promoter and coding regions of CXCL1, while there was no significant difference between all patients with UC and controls in their polymorphisms, except minor association at g.57A>G (rs2071425, p=0.02). On the other hand, among three novel and one known SNPs identified in the promoter region of CCL20, g. -1,706 G>A (p=0.000000055), g. -1,458 G>A (p=0.0048), and g. -962C>A (p=0.0006) were found to be significantly associated with the susceptibility of Uc. Conclusion: Altered gene expression in mononuclear cells may contribute to IBD pathogenesis. Although the findings need to be confirmed in other populations with larger numbers of patients, the current results demonstrated that polymorphisms in the promoter region of CCL20 are positively associated with the development of Uc.

Keywords

References

  1. Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI: Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 34;517-524, 1993 https://doi.org/10.1136/gut.34.4.517
  2. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, McElree CK, Pressman SR, Shanahan F, Targan SR: Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 104;741-748, 1993 https://doi.org/10.1016/0016-5085(93)91009-7
  3. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B: Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29;990-996, 1988 https://doi.org/10.1136/gut.29.7.990
  4. Taylor KD, Yang H, Rotter JI: Inflammatory bowel disease. II. Gene mapping. Mol Genet Metab 74;22-44, 2001 https://doi.org/10.1006/mgme.2001.3214
  5. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411;603-606, 2001 https://doi.org/10.1038/35079114
  6. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, Rosenstiel P, Albrecht M, Croucher PJ, Seegert D, Nikolaus S, Hampe J, Lengauer T, Pierrou S, Foelsch UR, Mathew CG, Lagerstrom-Fermer M, Schreiber S: Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36;476-480, 2004 https://doi.org/10.1038/ng1345
  7. Cho JH: Advances in the genetics of inflammatory bowel disease. Curr Gastroenterol Rep 6;467-473, 2004 https://doi.org/10.1007/s11894-004-0068-4
  8. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP: Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14;199-202, 1996 https://doi.org/10.1038/ng1096-199
  9. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM: Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 13;763-770, 2004 https://doi.org/10.1093/hmg/ddh090
  10. Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E, Herfarth H, Schoelmerich J, Gregor M, Walker S, Cascorbi I, Roots I, Brinkmann U, Zanger UM, Eichelbaum M: Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124;26-33, 2003 https://doi.org/10.1053/gast.2003.50010
  11. Zuo L, Ogle CK, Fischer JE, Nussbaum MS: mRNA differential display of colonic mucosa cells in ulcerative colitis. J Surg Res 69;119-127, 1997 https://doi.org/10.1006/jsre.1997.5041
  12. Lawrance IC, Fiocchi C, Chakravarti S: Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10;445-456, 2001 https://doi.org/10.1093/hmg/10.5.445
  13. Warner EE, Dieckgraefe BK: Application of genome-wide gene expression profiling by high-density DNA arrays to the treatment and study of inflammatory bowel disease. Inflamm Bowel Dis 8;140-157, 2002 https://doi.org/10.1097/00054725-200203000-00012
  14. Uthoff SM, Crawford NP, Eichenberger MR, Hamilton CJ, Petras RE, Martin ER, Galandiuk S: Association of ulcerative colitis with the inflammatory bowel disease susceptibility locus IBD2 in non-Jewish Caucasians and evidence of genetic heterogeneity among racial and ethnic populations with Crohn disease. Am J Med Genet 113;242-249, 2002 https://doi.org/10.1002/ajmg.10762
  15. Masuda H, Takahashi Y, Asai S, Takayama T: Distinct gene expression of osteopontin in patients with ulcerative colitis. J Surg Res 111;85-90, 2003 https://doi.org/10.1016/S0022-4804(03)00046-5
  16. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411;599-603, 2001 https://doi.org/10.1038/35079107
  17. Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, Zimmermann E, Tretiakova M, Cho JH, Hart J, Greenson JK, Keshav S, Nunez G: Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52;1591-1597, 2003 https://doi.org/10.1136/gut.52.11.1591
  18. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K: An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35;341-348, 2003 https://doi.org/10.1038/ng1267
  19. Truelove SC, Witts LJ: Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1041-1048, 1955 https://doi.org/10.1136/bmj.2.4947.1041
  20. Holland PM, Abramson RD, Watson R, Gelfand DH: Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88;7276-7280, 1991
  21. Isaacs KL, Sartor RB, Haskill S: Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103;1587-1595, 1992 https://doi.org/10.1016/0016-5085(92)91182-4
  22. Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC: Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut 51;818-826, 2002 https://doi.org/10.1136/gut.51.6.818
  23. Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP: Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther 15;731-748, 2001 https://doi.org/10.1046/j.1365-2036.2001.00981.x
  24. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT: A polymor-phism in the IL11 gene is associated with ulcerative colitis. Genes Immun 3;494-496, 2002 https://doi.org/10.1038/sj.gene.6363897
  25. Kojima Y, Kinouchi Y, Takahashi S, Negoro K, Hiwatashi N, Shimosegawa T: Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene. Tissue Antigens 58;379-384, 2001 https://doi.org/10.1034/j.1399-0039.2001.580606.x
  26. Parkes M, Satsangi J, Jewell D: Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol 113;28-32, 1998 https://doi.org/10.1046/j.1365-2249.1998.00625.x
  27. Frenzel H, Hampe J, Huse K, Mascheretti SM, Croucher PP, Lynch NJ, Siebert R, Platzer M, Schreiber S: Mutation detection and physical mapping of the CD11 gene cluster in association with inflammatory bowel disease. Immunogenetics 53;835-842, 2002 https://doi.org/10.1007/s00251-001-0411-y
  28. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT: Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun 2;287-289, 2001 https://doi.org/10.1038/sj.gene.6363779
  29. Low JH, Williams FA, Yang X, Cullen S, Colley J, Ling KL, Armuzzi A, Ahmad T, Neville MJ, Dechairo BM, Walton R, Lench NJ, Jewell DP: Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1. Inflamm Bowel Dis 10;173-181, 2004 https://doi.org/10.1097/00054725-200405000-00001
  30. Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H, Sakaki Y, Takatsuki K, Miura R, Yoshie O, Nomiyama H: Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 272;5846-5853, 1997 https://doi.org/10.1074/jbc.272.9.5846
  31. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G: Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379;821-823, 1996 https://doi.org/10.1038/379821a0
  32. Cho JH, Nicolae DL, Ramos R, Fields CT, Rabenau K, Corradino S, Brant SR, Espinosa R, LeBeau M, Hanauer SB, Bodzin J, Bonen DK: Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum Mol Genet 9;1425-1432, 2000 https://doi.org/10.1093/hmg/9.9.1425
  33. Hampe J, Lynch NJ, Daniels S, Bridger S, Macpherson AJ, Stokkers P, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S: Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut 48;191-197, 2001 https://doi.org/10.1136/gut.48.2.191
  34. Hampe J, Schreiber S, Shaw SH, Lau KF, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Buckler A, Hall J, Stokkers P, van Deventer SJ, Nurnberg P, Mirza MM, Lee JC, Lennard-Jones JE, Mathew CG, Curran ME: A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 64;808-816, 1999 https://doi.org/10.1086/302294
  35. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridger S, van Deventer S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S: Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 65;1647-1655, 1999 https://doi.org/10.1086/302677
  36. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, Green T, Brettin TS, Stone V, Bull SB, Bitton A, Williams CN, Greenberg GR, Cohen Z, Lander ES, Hudson TJ, Siminovitch KA: Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 66;1863-1870, 2000 https://doi.org/10.1086/302913
  37. Duerr RH: The genetics of inflammatory bowel disease. Gastroenterol Clin North Am 31;63-76, 2002 https://doi.org/10.1016/S0889-8553(01)00005-X